Identifying these cases, patients with WNT-activated medulloblastomas and CTNNB1 wild type have a high chance of harboring germline mutations in APC and should improve the patient’s treatment by differentiated surveillance and early cancer detection in patients and relatives resulting in more effective therapy (8). Here, CTNNB1 is linked to medulloblastoma.